Table 1

General characteristics in healthy controls, at-risk subjects and IS patients

Healthy control subjects (n=56)At-risk subjects (n=60)IS patients
(n=72)
Age (year)66.36±11.1968.64±10.1469.54±13.69
Gender (male/female)30/2638/2243/29
Smoking (n, %)6 (10.71)7 (11.67)8 (11.11)
Hypertension (n, %)--37 (62.67)49 (68.06)
Diabetes (n, %)--11 (18.33)15 (20.83)
Alcohol consumption (n, %)3 (5.36)2 (6.06)4 (5.56)
SBP129.23±18.11150.85±22.70*150.39±25.98*
DBP75.09±11.4180.82±11.7585.77±15.02*
CHOL (mmol/L)4.81±0.964.91±1.414.75±1.28
TG (mmol/L)1.05±0.321.81±1.22* + 1.30±1.00
HDL (mmol/L)1.42±0.361.48±0.501.54±0.67
LDL (mmol/L)2.94±1.013.25±1.672.74±0.99
Hcy (mmol/L)9.28±2.5511.83±4.25*11.51±4.68*
SUA (mmol/L)299.41±67.82320.68±101.39307.19±118.26
Ultrasound parameters
IMT (mm)0.85±0.191.03±0.21*1.06±0.20*
Carotid atherosclerosis (n, %)2 (3.57)34 (56.67)*44 (61.11)*
Plaque (n, %)3 (5.00)37 (61.67)*42 (58.33)*
IS subgroups
LAA (n, %)----30 (41.67)
CE (n, %)----23 (31.94)
SAA (n, %)----14 (19.44)
SUE (n, %)----4 (5.56)
NIHSS <7 (n, %)----40 (55.56)
NIHSS ≥7 (n, %)----32 (44.44)
  • *p<0.05, vs normal control; +p<0.05, vs IS patients.

  • CE, cardioembolism; CHOL, cholesterol; DBP, diastolic blood pressure; Hcy, homocysteine; HDL, high-density lipoprotein; IMT, intima—media thickness; IS, ischaemic stroke; LAA, large artery atherosclerosis; LDL, low density lipoprotein; SBP, systolic blood pressure; SUA, serum uric acid; SUE, stroke of undetermined cause; TG, triglyceride.